Analytical Data
-
Gene name
EVI2B
- Application
-
Alternative Names
EVI2B; EVDB; Protein EVI2B; EVI-2B; CD antigen CD361
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P34910
-
Expression Region
1-448aa
-
AA Sequence
MDPKYFILILFCGHLNNTFFSKTETITTEKQSQPTLFTSSMSQVLANSQNTTGNPLGQPTQFSDTFSGQSISPAKVTAGQPTPAVYTSSEKPEAHTSAGQPLAYNTKQPTPIANASSQQAVFTSARQLPSARTSTTQPPKSFVYTFTQQSSSVQIPSRKQITVHNPSTQPTSTVKNSPRSTPGFILDTTSNKQTPQKNNYNSIAAILIGVLLTSMLVAIIIIVLWKCLRKPVLNDQNWAGRSLFADGETPGICMDNIRENEISTKRTSIISLTPWKPSKSTLLADDLEIKLFESSENIEDSNNPKTEKIKDQVNGTSEDSADGSTVGTAVSSSDDADLPPPPPLLDLEGQESNQSDKPTMTIVSPLPNDSTSLPPSLDCLNQDCGDHKSEIIQSFPPLDSLNLPLPPVDFMKNQEDSNLEIQCQEFSIPPNSDQDLNESLPPPPAELL
-
Molecular Weight
75.68 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EVI2B, or Ecotropic Viral Integration Site 2B, is a protein that has gained attention in the field of molecular biology and oncology due to its potential roles in cell signaling, proliferation, and differentiation. Initially identified in the context of retroviral integration, EVI2B has been implicated in various cellular processes, making it a subject of interest for understanding tumorigenesis and immune responses. Recent research has suggested that EVI2B may play a critical role in the regulation of important signaling pathways, including those involved in cancer progression and metastasis. Studies have shown that altered expression levels of EVI2B can influence cellular behavior, thereby contributing to the understanding of its function in different cancer types. Moreover, its involvement in immune system regulation adds another layer to its significance, suggesting a dual role in both tumor biology and potential therapeutic interventions. As a result, the investigation of EVI2B recombinant proteins has emerged as a promising avenue for exploring its biological functions, developing diagnostic tools, and creating targeted therapies for cancer treatment. Understanding the molecular mechanisms underlying EVI2B's actions could offer valuable insights into novel approaches for cancer management and enhance our knowledge of cellular dynamics in health and disease.
